Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India Plans To End Dependence On China Bulk Imports By 2020

This article was originally published in PharmAsia News

Executive Summary

India says it is aiming to end its dependence on Chinese bulk drug imports by 2020 as it announces plans to set up a string of pharmaceutical industrial parks to boost manufacturing capacity.



Related Companies